Although docetaxel induces ELK3 protein degradation through SPOP-mediated ubiquitination, PCa-associated SPOP mutants did not disrupt ELK3 protein abundance, even under docetaxel treatment. The gene discussed is ELK3; the disease is posterior cortical atrophy.